INS and Hyperglycemia: In both pancreas and islet transplantation, when there is suspicion of (acute cellular) allograft rejection with hyperglycemia and the necessity for insulin, there is a similar reluctance to use high-dose GCs partly due to its hyperglycemic effects12 and the notion that irreversible islet damage has already occurred.